Atorvastatin Calcium
Product Images NDC 45865-743

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 45865-743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (743)

Atorvastatin Calcium Tablets 10 mg packaging label from medsource pharmaceuticals. The label indicates the product is a generic version of Lipitor and comes in white, round, film-coated tablets. It includes warnings about grapefruit and alcohol use, dosage instructions to take one tablet daily or as directed, and features the product NDC 45865-0743-49.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

Chemical structure diagram of atorvastatin calcium, showing its molecular components including phenyl groups, hydroxyl groups, fluorine, calcium ion, and water of hydration.*

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

A cumulative incidence line graph comparing Atorvastatin and placebo over a period of 3.5 years. The x-axis represents years, and the y-axis shows cumulative incidence percentage. The graph includes hazard ratio (HR=0.64) with confidence intervals and a p-value (0.0005), illustrating a lower incidence for Atorvastatin compared to placebo.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

A cumulative hazard plot comparing Atorvastatin and placebo over four years of follow-up. The graph shows time to first primary endpoint on the x-axis (0 to 5 years) and cumulative hazard percentage on the y-axis (0% to 15%). Atorvastatin data is represented with a solid line, showing a lower cumulative hazard than the placebo, which is shown with a dashed line. The plot includes a hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and a p-value of 0.001.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

A Kaplan-Meier curve chart comparing the percentage of subjects experiencing the first major cardiovascular endpoint over time between two Atorvastatin dosages: 10 mg (dashed line) and 80 mg (solid line). The x-axis represents time in years up to 5 years, and the y-axis shows the percentage of subjects experiencing the event up to 0.2 (20%). Hazard ratio and p-value are noted at the lower right corner.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.